21 completed, 1 unknown. 22 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 22 | Completed 21, Unknown 1 |
Follow Hiberix: new trials by email Literature Review of Hiberix trials Research Report on Hiberix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) V114, Prevnar 13™, RotaTeq™ - Pneumococcal Infections, Pneumococcal Vaccines | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1720 | 2019-06-19 | 2023-07-28 |
| A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION) Prevnar 13™, V114, RotaTeq™ - Pneumococcal Infections | Phase 3 | Completed | Merck Sharp & Dohme LLC | 900 | 2018-10-18 | 2023-01-17 |
| Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ), Prevnar13, Pediarix - Infections, Meningococcal | Phase 3 | Completed | GlaxoSmithKline | 1196 | 2018-07-27 | 2026-08-20 |
| This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine Rotarix, Pediarix, Hiberix - Rotavirus Infection, Rotavirus Vaccines | Phase 3 | Completed | GlaxoSmithKline | 1280 | 2017-09-14 | 2020-12-29 |
| Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine,Freeze-dried Minhai-HIB, Act-HIB® - Haemophilus Influenzae Type b Infections | Phase 3 | Unknown | Beijing Minhai Biotechnology Co., Ltd | 1560 | 2014-09-01 | 2015-09-25 |
| Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants Infanrix hexa, Pediarix, ActHIB - Poliomyelitis, Diphtheria | Phase 3 | Completed | GlaxoSmithKline | 585 | 2014-04-16 | 2019-11-27 |
| Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine Infanrix™-IPV+Hib, Infanrix™ IPV, Hiberix™ - Poliomyelitis, Tetanus | Phase 3 | Completed | GlaxoSmithKline | 454 | 2011-03-04 | 2019-11-27 |
| Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108), ActHIB™, Pentacel™ - Haemophilus Influenzae Type b | Phase 3 | Completed | GlaxoSmithKline | 4003 | 2010-06-18 | 2018-07-12 |
| A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants DTaP//PRP-T Combined Vaccine, DTaP Combined Vaccine and PRP-Tetanus Conjugate Vaccine - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi | 1056 | 2010-01-01 | 2011-12-13 |
| Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine), Hiberix (Haemophilus influenzae type b (Hib) vaccine) - Haemophilus Influenzae Type b (Hib) Infection | Phase 3 | Completed | Novartis Vaccines | 846 | 2009-09-01 | 2011-12-08 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age Pneumococcal conjugate vaccine GSK1024850A, Tritanrix-HepB/Hib, Hiberix - Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Completed | GlaxoSmithKline | 360 | 2009-03-07 | 2020-01-03 |
| Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children Infanrix™, Hiberix™ - Acellular Pertussis, Diphtheria | Phase 3 | Completed | GlaxoSmithKline | 467 | 2008-06-07 | 2018-06-06 |
| Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines Synflorix, Tritanrix-HepB, Hiberix - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 756 | 2007-10-22 | 2019-01-14 |
| Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib Zilbrix-Hib, Tritanrix™-HepB/ Hiberix™ - Whole Cell Pertussis, Haemophilus Influenzae Type b | Phase 3 | Completed | GlaxoSmithKline | 300 | 2007-06-01 | 2017-08-18 |
| Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib, Diphtheria, Tetanus, & Acellular Pertussis Combined, Absorbed - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi | 792 | 2007-03-01 | 2012-04-17 |
| Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib. Infanrix™/Hib, Infanrix, Hiberix - Tetanus, Diphtheria | Phase 3 | Completed | GlaxoSmithKline | 660 | 2007-01-03 | 2018-06-06 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine Pneumococcal conjugate vaccine GSK1024850A, Prevenar, Tritanrix-HepB - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 806 | 2006-08-07 | 2018-12-07 |
| Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years. Haemophilus influenzae type b and meningococcal serogroup C (vaccine), Priorix™, Hiberix™ - Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 3 | Completed | GlaxoSmithKline | 433 | 2006-06-01 | 2018-08-24 |
| Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects Tritanrix™- HepB, Hiberix™, Mencevax™ ACW - Infections, Meningococcal | Phase 3 | Completed | GlaxoSmithKline | 168 | 2006-04-19 | 2018-06-06 |
| Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study Tritanrix™- HepB, Hiberix™, Mencevax™ ACWY - Infections, Meningococcal | Phase 3 | Completed | GlaxoSmithKline | 296 | 2006-02-01 | 2018-06-06 |
Showing 20 of 22. Sign in to see all of them.
Haemophilus Infections (13) · Tetanus (11) · Diphtheria (9) · Hepatitis B (6) · Whooping Cough (6) · Pneumococcal Infections (5) · Poliomyelitis (4) · Meningococcal Infections (3) · Streptococcal Infections (3) · Gram-Negative Bacterial Infections (1) · Infections (1) · Meningitis (1) · Meningitis, Meningococcal (1) · Rotavirus Infections (1)
GlaxoSmithKline (16) · Merck Sharp & Dohme LLC (2) · Sanofi (2) · Beijing Minhai Biotechnology Co., Ltd (1) · Novartis Vaccines (1)
China (6) · United States (6) · Philippines (4) · Puerto Rico (3) · India (2) · Poland (2) · Thailand (2) · Turkey (Türkiye) (2) · Australia (1) · South Africa (1) · South Korea (1)
PMID 19325447, PMID 19325451, PMID 19325452, PMID 21219984, PMID 22001281, PMID 22349525, PMID 25008901, PMID 36522265, PMID 36621410, PMID 37846456
2016 (2), 2018 (2)